Page URL:

Emma Laycock

Dr Emma Laycock is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She is a Policy Officer at the Academy of Medical Sciences and previously studied for a PhD in Stem Cell Biology at University College London's Cancer Institute, modelling how childhood leukaemia develops in utero. Prior to this, she worked as a Journal Development Editor at BioMed Central, responsible for a cluster of biotechnology journals. She originally studied Biomedical Science at the University of Warwick, and her degree included an intercalated year at the National Institute for Biological Standards and Control and a summer placement at the National University of Ireland in Galway, studying whooping cough and water contaminants respectively. She tweets as @EmmaVLaycock

BioNews Comment articles written by Emma Laycock:
Page 1 of 1
Science marches on: key scientific developments in embryo research
7 January 2019 - by Emma Laycock
'Science marches on' was the third session of the Progress Educational Trust (PET)'s Annual Conference 'Make Do or Amend: Should We Update UK Fertility and Embryo Law?'. The session focused on the key scientific developments within embryo research asking: where are we now, what can we learn from past battles and, most importantly, where are we going?... [Read More]

BioNews Review articles written by Emma Laycock:
Page 1 of 1
Podcast Review: CRISPR Updated
27 March 2017 - by Emma Laycock
Radiolab explores the science, the uses and the ethics of CRISPR in this podcast that was two years in the making... [Read More]

BioNews News articles written by Emma Laycock:
Page 1 of 2
Male couple expecting baby after NHS IVF
11 May 2020 - by Emma Laycock
The first male same-sex couple to receive IVF on the NHS has announced they are expecting a baby son via surrogate this summer... [Read More]
Novel mutations in stem cells of young donors can be passed to recipients
20 January 2020 - by Emma Laycock
A new study suggests that rare harmful mutations in young healthy donors' stems cells can be passed on to recipients of stem cell transplants, potentially leading to health problems... [Read More]
US disability council urges greater regulation of genetic testing
4 November 2019 - by Emma Laycock
The US National Council on Disability (NCD) has published a new report calling for greater oversight of genetic testing, particularly prenatal testing... [Read More]
Blood test detects ovarian cancer two years earlier
27 August 2019 - by Emma Laycock
Scientists have developed a blood test that may be able to detect ovarian cancer up to two years earlier than other methods... [Read More]
New blood test could help diagnose ovarian cancer
24 June 2019 - by Emma Laycock
Scientists have discovered a set of biomarkers in the blood that could indicate ovarian cancer, which could be used to help diagnose the disease... [Read More]
Stress during military conflict lowers sperm quality
11 June 2018 - by Emma Laycock
Scientists in Israel have linked prolonged stress during outbreaks of Israeli-Palestinian conflict with lowered sperm quality in Israeli men... [Read More]
Painkillers in pregnancy may affect offspring's fertility
23 April 2018 - by Emma Laycock
Taking painkillers during pregnancy could affect the future fertility of the fetus, suggests research on human tissue and in mice... [Read More]
Human trophoblast stem cells cultured for first time
29 January 2018 - by Emma Laycock
Scientists in Japan have cultured human trophoblast stem cells, which form the placenta, for the first time... [Read More]
Large volumes of stem cells collected during caesareans
11 December 2017 - by Emma Laycock
An efficient method to collect amniotic fluid rich in stem cells during caesarean sections has been developed by scientists in Sweden... [Read More]
'CRISPR-Gold' repairs muscular dystrophy gene in mouse model
9 October 2017 - by Emma Laycock
Scientists have repaired the faulty gene in a mouse model of muscular dystrophy by using gold nanoparticles to deliver the genome editing tool CRISPR-Cas9... [Read More]